| COVID-19 vaccination and breakthrough infections in patients with cancer AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ... Annals of oncology 33 (3), 340-346, 2022 | 88 | 2022 |
| HLA-A* 03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study V Naranbhai, M Viard, M Dean, S Groha, DA Braun, C Labaki, SA Shukla, ... The Lancet Oncology 23 (1), 172-184, 2022 | 63 | 2022 |
| Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors AH Nassar, E Adib, S Abou Alaiwi, T El Zarif, S Groha, EW Akl, PV Nuzzo, ... Cancer Cell 40 (10), 1161-1172. e5, 2022 | 54 | 2022 |
| Integrative clinical and molecular characterization of translocation renal cell carcinoma Z Bakouny, A Sadagopan, P Ravi, NY Metaferia, J Li, S AbuHammad, ... Cell reports 38 (1), 2022 | 52 | 2022 |
| Germline variants associated with toxicity to immune checkpoint blockade S Groha, SA Alaiwi, W Xu, V Naranbhai, AH Nassar, Z Bakouny, T El Zarif, ... Nature medicine 28 (12), 2584-2591, 2022 | 47 | 2022 |
| Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey E Moujaess, NB Zeid, R Samaha, J Sawan, H Kourie, C Labaki, R Chebel, ... Future Oncology 17 (31), 4071-4079, 2021 | 44 | 2021 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 38 | 2021 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 29 | 2023 |
| The use of mirabegron in neurogenic bladder: a systematic review E El Helou, C Labaki, R Chebel, J El Helou, G Abi Tayeh, G Jalkh, E Nemr World Journal of Urology 38, 2435-2442, 2020 | 29 | 2020 |
| Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and … TK Choueiri, C Labaki, Z Bakouny, CY Hsu, AL Schmidt, G de Lima Lopes, ... The Lancet Regional Health–Americas 19, 2023 | 27 | 2023 |
| Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic C Labaki, Z Bakouny, A Schmidt, SR Lipsitz, TR Rebbeck, QD Trinh, ... Cancer cell 39 (8), 1042-1044, 2021 | 27 | 2021 |
| Influence of spino-pelvic and postural alignment parameters on gait kinematics J Otayek, AJ Bizdikian, F Yared, E Saad, Z Bakouny, A Massaad, ... Gait & Posture 76, 318-326, 2020 | 22 | 2020 |
| Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study Z Bakouny, C Labaki, S Bhalla, AL Schmidt, JA Steinharter, J Cocco, ... Annals of Oncology 33 (8), 836-844, 2022 | 21 | 2022 |
| Outcomes for international metastatic renal cell carcinoma database consortium prognostic groups in contemporary first-line combination therapies for metastatic renal cell … MS Ernst, V Navani, JC Wells, F Donskov, N Basappa, C Labaki, SK Pal, ... European Urology 84 (1), 109-116, 2023 | 20 | 2023 |
| Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium A Elkrief, C Hennessy, NM Kuderer, SM Rubinstein, E Wulff-Burchfield, ... The Lancet Healthy Longevity 3 (3), e143-e152, 2022 | 19 | 2022 |
| Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors E Yekedüz, D Trapani, W Xu, EGE de Vries, C Labaki, B Gyawali, S Gulati, ... International journal of cancer 149 (7), 1455-1462, 2021 | 18 | 2021 |
| First-line treatments for metastatic clear cell renal cell carcinoma: an ever-enlarging landscape S Gulati, C Labaki, GS Karachaliou, TK Choueiri, T Zhang The oncologist 27 (2), 125-134, 2022 | 17 | 2022 |
| Systematic review of the CUP trials characteristics and perspectives for next-generation studies E Rassy, C Labaki, R Chebel, S Boussios, J Smith-Gagen, FA Greco, ... Cancer Treatment Reviews 107, 102407, 2022 | 16 | 2022 |
| From basic science to clinical translation in kidney cancer: a report from the second kidney cancer research summit TK Choueiri, L Albiges, MB Atkins, Z Bakouny, G Bratslavsky, DA Braun, ... Clinical Cancer Research 28 (5), 831-839, 2022 | 15 | 2022 |
| Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19 SM Rubinstein, D Bhutani, RC Lynch, CY Hsu, Y Shyr, S Advani, ... Blood cancer discovery 3 (3), 181-193, 2022 | 14 | 2022 |
Ziad BakounyMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
